Acorda Therapeutics Q2 Profit Rises - Quick Facts

(RTTNews) - Acorda Therapeutics, Inc. (ACOR) reported that its second-quarter net income increased to $4.7 million or $0.11 per share, from $3.9 million, or $0.09 per share, last year. Non-GAAP net income was $17.7 million, or $0.42 per share, for the quarter.

On average, 11 analysts polled by Thomson Reuters expected the company to report profit per share of $0.15 for the quarter. Analysts' estimates typically exclude special items.

Total revenues rose to $97.13 million from $87.05 million, prior year. Analysts expected revenue of $91.42 million for the quarter.